Research on transdermal delivery of herbal extracts for metabolic effects is limited
So I think one helpful way to think about this is if the drug is working so aggressively that you cant nourish yourself, cant train well, and dont feel like yourself, thats not automatically a win
Also, a peer-reviewed study published by earlier this year by the research journal Obesity indicates that only 40% of obese patients taking semaglutide-based GLP-1 products were persistent at one year
The average American woman aged 40 to 49 years old needs to lose ~30 lbs to reach a normal healthy weight
In clinical trials, diarrhea is a common side effect, occurring in approximately 30% of patients taking Wegovy (semaglutide 2.4 mg) and 19-23% of patients taking Zepbound (tirzepatide), according to FDA prescribing information
These patches lack scientific evidence and have provided potential results only in certain trial-based studies, which cannot be considered safe